by Mike Masnick
Wed, May 13th 2009 8:52am
For years, we've been among those who have questioned how the hell anyone (let alone the US Patent Office) can justify the concept of patenting genes. Yet, the Patent Office has continued to issue such patents, even as they have been shown to cause significant problems in diagnosing and treating certain illnesses. Finally, however, it appears that the concept of patenting genes is about to get tested in court. The ACLU has organized a group of cancer patients who have had treatments and medical analysis limited due to gene patents held by the company Myriad Genetics, and brought the issue to court. This is a big deal... and while the case and the resulting appeals will certainly take many years, this is going to be a case well worth watching.
If you liked this post, you may also be interested in...
- 'Officer Awareness' Memo: Police Accountability Recording App Could Lead To Dangerous 'Flash Mobs'
- 532,900,000 Reasons Why We Need Patent Reform Now
- Cerf Warns Of A 'Lost Century' Caused By Bit Rot; Patents And Copyright Largely To Blame
- Elon Musk Clarifies That Tesla's Patents Really Are Free; Investor Absolutely Freaks Out
- Myriad Genetics Finally Gives Up Its Gene Patent Fight... Just As The Patent Office Opens The Doors Up To More Gene Patents